Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.

@article{Bounfour2014ClinicalEO,
  title={Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.},
  author={Touda Bounfour and J-D Bouaziz and Maud B{\'e}zier and Florence Cordoliani and Anne Saussine and Antoine Petit and Caroline Juillard and Martine Bagot and Michel Rybojad},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2014},
  volume={28 9},
  pages={1150-7}
}
BACKGROUND Treating dermatomyositis (DM) with isolated skin involvement is difficult and inconsistently performed. Intravenous immunoglobulins (IVIg) are recommended for corticoresistant or corticodependant DM, but only a few cases of IVIg use in DM with isolated skin involvement have been reported. DESIGN We performed a retrospective monocentric study of 27 patients who were treated with IVIg for severe DM skin lesions (no or minor muscle involvement) after failure of photoprotection and at… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS